 |
|
|
| |
One Year Outcome of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed Children
≥ 2 Years Weighing 14 to < 25 kg
|
| |
| |
International Workshop on HIV & Pediatrics 2022, 27–28 July 2022, Montréal, Québec, Canada
Carina A. Rodriguez,1 Renate Strehlau,2 Kulkanya Chokephaibulkit,3 Esme L. Venter E,4 Umesh Lalloo,5
Eva Natukunda,6 Eric McGrath,7 Elizabeth Hellstrӧm,8 Afaaf Liberty,9 Riana Van Zyl,10 Pope Kosalaraksa,11 Shaolan Xiang,12 Kristen Andreatta,12 Heather Maxwell,12 Vinicius A. Vieira,12 Jason Hindman,12
Kathryn Kersey,12 Mark Cotton,13 Aditya H. Gaur14
|
| |
|
|
|
|
|
